Med Holdings Group Inc. (OTC: YUKA) today announced it has entered into advanced negotiations with nationally recognized urology and sexual wellness specialist Dr. Harvey Samowitz, a move that would significantly strengthen the Company's clinical leadership as it rapidly expands its footprint and national platform.
Dr. Samowitz brings more than 30 years of experience in urology, sexual medicine, and pelvic health. Board certified by the American Board of Urology and subspecialty certified in Female Pelvic Medicine and Reconstructive Surgery, he is widely respected for his clinical expertise, published research, and leadership within the urological community. His affiliations include the American Urological Association (AUA), Southeastern Section, American College of Surgeons, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU), among others.
“This is a defining moment for Med Holdings Group,” stated Jessica Miller, Chief Executive Officer of Med Holdings Group Inc. “Our strategy is simple: align with elite medical leadership, scale into high-demand markets, accelerate compliance milestones, and build a nationally recognized brand. Dr. Samowitz’s potential involvement reflects the caliber of professionals we are bringing into our ecosystem as we position the Company for sustained growth and shareholder value creation.”
Med Holdings Group is currently in active negotiations for two additional locations in Jupiter, Florida, and Doral, Florida. These markets align directly with the Company's demographic strategy and high-income target base. Management anticipates these additions will materially strengthen recurring revenue and regional brand dominance.
The Company is accelerating completion of its audit process while actively advancing its FINRA name change and ticker symbol change. These steps are intended to enhance transparency, strengthen corporate alignment, and increase market visibility as the Company scales operations.
Med Holdings Group has officially launched its enhanced national platform, TotallBody.com, significantly expanding its addressable market beyond brick-and-mortar locations. The platform provides immediate national brand exposure, access to a large underserved U.S. market, and scalable digital engagement for services and future vertical expansion. Management views this as a foundational step toward building a nationally scalable healthcare platform.
Over the past twelve months, YUKA has appreciated more than 500%, with the Company's market capitalization now exceeding $3 million. Management believes this growth reflects increasing investor awareness and recognition of the Company's strategic direction and execution.
With committed expansion capital, a clear acquisition and multi-location rollout strategy, accelerating compliance and corporate milestones, expanding clinical leadership, and a scalable national digital infrastructure, Med Holdings Group Inc. believes it is strategically positioned for continued operational and market growth into 2026 and beyond.
